Phase II Study for the Second-Line Treatment of Hypertension in Patients With Autosomal Dominant Polycystic Kidney Disease; ACEI vs. CCB.

Trial Profile

Phase II Study for the Second-Line Treatment of Hypertension in Patients With Autosomal Dominant Polycystic Kidney Disease; ACEI vs. CCB.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Cilnidipine (Primary) ; Imidapril (Primary) ; Candesartan cilexetil
  • Indications Hypertension
  • Focus Adverse reactions
  • Most Recent Events

    • 03 Dec 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov
    • 25 Jun 2009 Planned initiation date changed from 1 May 2009 to 1 Jul 2009 as reported by ClinicalTrials.gov.
    • 07 May 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top